# Bundang Rehabilitative Impact Study of the Elbow Epicondylitis

> **NCT02492945** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 40 (actual)

## Conditions studied

- Lateral Epicondylitis

## Interventions

- **DRUG:** 3ml-Rejuvinex
- **DRUG:** 3ml-15%-dextrose solution

## Key facts

- **NCT ID:** NCT02492945
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492945, "Bundang Rehabilitative Impact Study of the Elbow Epicondylitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02492945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*